Sorrento Therapeutics Inc (SRNE)

[dia76ca]

2 big reasons why most small biotech stock prices have declined.
1. Sector Rotation. Biotechs were very high early in the year. They are now such bargains that their share prices will soon move up!
2. Tax Loss selling. Most tax loss selling has already occurred. Most sellers want to be able to repurchase(after 30 days) to share in the expected January market rise.

3 big reasons why Sorrento share price will increase dramatically.
1. ABIVERTINIB global $61 billion market partnership(s). This will be a multi-billion, worldwide, upfront, milestone and royalty deal. This alone will fund Sorrento's other 75 programs.
2. COVISTIX revenue stream. Sales are being recorded in Q4 of 2021 and will dramatically increase in Q1 of 2022. Europe, Central and South America, Canada and Japan will soon be on stream. Even the US may catch up!
3. In Q1 of 2022 there will be important trial results from COVI-AMG, COVIDROPS, COVI-MSC, SP-102 and ABIVERTINIB(NSCLC). There could be several more EUA's and marketing could begin for SP-102 and ABIVERTINIB in 2H of 2022.
Investors say "SHOW US THE MONEY"...and that will happen big time in 2022!